Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Pricing Reforms Tested In Freewheeling Guangdong Could Be Extended Across China

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Pharmaceutical pricing reforms now being tested in the export powerhouse province of Guangdong could be adopted China-wide if they prove successful in balancing the longstanding government goal of making essential drugs affordable for a widening sector of the populace and the newer aim of rewarding innovative drugs with higher price levels

You may also be interested in...



China's Leading Medical Consumables Device Maker Weigao Plans New Share Offering In Hong Kong; JV With MNCs To Explore New Landscape

SHANGHAI - Weihai-based Shandong Weigao Group Medical Polymer Company Limited, the leading Chinese medical consumables manufacturer and Medtronic Inc., which holds 15% of its total stake, is planning a secondary offering of 85.6 million H shares in Hong Kong to raise roughly HK$1.736 billion ($223 million) to expand its production capability and fund potential merger and acquisitions

China's Leading Medical Consumables Device Maker Weigao Plans New Share Offering In Hong Kong; JV With MNCs To Explore New Landscape

SHANGHAI - Weihai-based Shandong Weigao Group Medical Polymer Company Limited, the leading Chinese medical consumables manufacturer and Medtronic Inc., which holds 15% of its total stake, is planning a secondary offering of 85.6 million H shares in Hong Kong to raise roughly HK$1.736 billion ($223 million) to expand its production capability and fund potential merger and acquisitions

American Chamber In China Calls For Streamlined Regulations For Medical Devices

SHANGHAI- The International Monetary Fund recently forecast that China's economy will surpass America and become the world's largest economy in 2016, which means it is more important than ever for U.S. companies to conduct business in China. But government transparency and a level playing field is still the biggest challenge for U.S. companies to operate in China, according to an April 26 white paper released by the American Chamber of Commerce in China

Related Content

UsernamePublicRestriction

Register

ID1132327

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel